Cardiovascular Risks Resurface Old Concerns About Sulfonylureas for T2D

(MedPage Today) — Sulfonylureas were flagged for excess cardiovascular risk when used for additional glucose lowering in type 2 diabetes (T2D) in an observational comparative effectiveness study.
As second-line therapies atop metformin, individual…